Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Takeda, Wipro Enter Global IT Platform Pact | Contract Pharma
Breaking News

Takeda, Wipro Enter Global IT Platform Pact

Wipro to build and maintain an "as-a-service" global platform

Wipro Ltd. has entered a strategic partnership with Takeda Pharmaceutical Co. to consolidate its IT platforms across the organization. Wipro will be the primary provider of IT Infrastructure management services and will build and maintain an “as-a-service” global platform for Takeda aimed at driving synergies across its global entities through standardization of IT architecture.

Sangita Singh, chief executive officer of Healthcare and Life Science Business Unit at Wipro said, “We are thrilled to partner with Takeda in its business transformation journey. Wipro is leveraging its experience in enabling global pharma companies to achieve a leaner & standardized IT workplace and implement newer business models that put patient at the core. We look forward to collaboratively partnering with the Takeda team in enabling this unique platform across its global operations.”
 
“Wipro will deliver the ‘as-a-service’ on demand model, which is redefining the way organizations purchase technology. With our global delivery capabilities, Wipro will drive Takeda’s IT infrastructure, consolidating and optimizing resources across the organization,” added G K Prasanna, chief executive officer of Global Infrastructure Services & Product Engineering Services.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters